Back to search

Article

Identification ACTA2 and KDR as Key Proteins for Prognosis of PD-1/PD-L1 Blockade Therapy in Melanoma

2020-07-02

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Programmed cell death protein 1 (PD-1) /programmed cell death ligand 1 (PD-L1) blockade is an important therapeutic strategy for melanoma, despite its low clinical response. It is important to identify genes and pathways that may reflect the clinical outcomes of this therapy in patients. <bold>Methods</bold>: In this study, we analyzed clinical dataset GSE96619,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f944c0dc-0c95-5841-94b7-b480547ea108
DOI
10.21203/rs.3.rs-38692/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification ACTA2 and KDR as Key Proteins for Prognosis of PD-1/PD-L1 Blockade Therapy in MelanomaDOI 10.21203/rs.3.rs-38692/v1
Select a neighboring publication to make it the new centre.